BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 29, 2003
View Archived Issues
Genentech, Xoma's Raptiva Receives Psoriasis Approval
Genentech Inc. and partner XOMA Ltd. won FDA approval for Raptiva, a biologic for psoriasis that can be self-administered once weekly on a continuous basis. (BioWorld Today)
Read More
Avonex Boosts Biogen Again; Psoriasis Drug Proves Weaker
Read More
Novel Strategies To Expand Blood Stem Cells In Mice Look Likely In People, Too; Clinical Trials Impend
Read More
Avera In-Licenses From Novartis Anxiety, Depression Compound
Read More
Other News To Note
Read More